Short-Term Moderate-Dose Corticosteroid Plus Immunoglobulin Effectively Reverses COVID-19 Patients Who Have Failed Low-Dose Therapy
doi 10.20944/preprints202003.0065.v1
Full Text
Open PDFAbstract
Available in full text
Date
March 4, 2020
Authors
Publisher
MDPI AG